(Q44386230)

2 December 2017

title

Costs associated with outpatient, emergency room and inpatient care for migraine in the USA. (English)

1 reference

2 December 2017

1 reference

Ralph P Insinga

1

1 reference

2 December 2017

Daisy S Ng-Mak

series ordinal

2

1 reference

2 December 2017

Mary E Hanson

series ordinal

3

1 reference

2 December 2017

language of work or name

English

0 references

publication date

19 October 2011

1 reference

2 December 2017

1 reference

2 December 2017

volume

31

1 reference

2 December 2017

issue

15

1 reference

2 December 2017

page(s)

1570-1575

1 reference

Migraine prevalence, disease burden, and the need for preventive therapy

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0333102411425960

Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411425960

Burden of migraine in the United States: disability and economic costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411425960

The multinational impact of migraine symptoms on healthcare utilisation and work loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411425960

Economic evaluation of pharmacotherapy of migraine pain: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411425960

Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411425960

Impact of a group-based model of disease management for headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411425960

Incidence and predictors for chronicity of headache in patients with episodic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411425960

Triptan persistency among newly initiated users in a pharmacy claims database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411425960

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411425960

Triptans: low utilization and high turnover in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102411425960

21 January 2018

Identifiers

DOI

10.1177/0333102411425960

1 reference

2 December 2017

1 reference